PrintAdd This

In 2002, a study published in the Archives of Neurology found that patients who took 1,200 mgs of Coenzyme Q10 daily, experienced slower Parkinson's deterioration than those that took a placebo. Based on these results many physicians are supporting their patient's decision to supplement their diet with CoQ10.

All CoQ10 Products are Not Equal!

  • Vitaline is the only CoQ10 product proven safe and effective in over 25 independent clinical studies.
  • Vitaline is an ALL NATURAL form of CoQ10. Other brands use less effective synthetic ingredients.
  • Vitaline has a proprietary fatty acid delivery system, not available to other manufacturers.

Vitaline's formula is the only CoQ10 supplement that has been independently proven to:

  • Absorb into the blood stream
  • Spike serum levels
  • Cross the cell wall
  • Spike mitochondrial levels
  • Cross the blood brain barrier
  • Improve the overall health of patients

Hope Digest has made special arrangements with Vitaline Formulas to save you 33% off the regular retail price of $200.00 - a total savings of $66.00. Sign up today and a Vitaline Representative will contact you to help you get your first month's supply for only $134.00*.

1. Shults C et al. Effects of Coenzyme Q10 in Early Parkinson Disease Arch Neurol. 2002;59:1541-50.

* New customers only. Discount available for up to a 3 month supply based 1200 mg per day. This offer is only available to shipping addresses within the United States.

Fill out the form below and a Vitaline CoQ10 specialist will contact you. You will also receive periodic information from Hope Digest.

First Name:
 
Last Name:
 
Address:
 
City:
 
State:
 
Zip:
 
Phone:
 
Time to Call:
 
Email:
 
   By checking this box and hitting the Submit button, I agree to allow a representative to call me on the phone or e-mail me with information about Vitaline CoQ10. I also agree to receive periodic information via e-mail from Hope Digest and its partners
 
203caf2889d40fd8980660895ecc2bd0e3061e1c
Please type the characters from the image above.